1. Home
  2. OLMA vs ATEC Comparison

OLMA vs ATEC Comparison

Compare OLMA & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olema Pharmaceuticals Inc.

OLMA

Olema Pharmaceuticals Inc.

HOLD

Current Price

$13.74

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Alphatec Holdings Inc.

ATEC

Alphatec Holdings Inc.

HOLD

Current Price

$7.58

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLMA
ATEC
Founded
2006
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
OLMA
ATEC
Price
$13.74
$7.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
11
Target Price
$44.89
$22.00
AVG Volume (30 Days)
785.9K
4.4M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
15.00
15.04
EPS
N/A
N/A
Revenue
N/A
$101,739,000.00
Revenue This Year
N/A
$18.97
Revenue Next Year
N/A
$16.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.89
$6.82
52 Week High
$36.26
$23.29

Technical Indicators

Market Signals
Indicator
OLMA
ATEC
Relative Strength Index (RSI) 35.26 36.63
Support Level $13.11 N/A
Resistance Level $17.23 $16.22
Average True Range (ATR) 0.81 0.67
MACD -0.05 -0.15
Stochastic Oscillator 28.41 20.07

Price Performance

Historical Comparison
OLMA
ATEC

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About ATEC Alphatec Holdings Inc.

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.

Share on Social Networks: